Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Acta Dermato-Venereologica|September 19, 2022
Sustained Resolution of Nail Psoriasis Through 5 Years with Ixekizumab: A Post-Hoc analysis from UNCOVER-3Alexander Egeberg, Lars Erik Kristensen, Ronald Vender, et al.
The Journal of Dermatological Treatment|April 18, 2020
Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12Alice B Gottlieb, Daniel Saure, Stefan Wilhelm, et al.
The Journal of Investigative Dermatology|November 12, 2018
A Preclinical Model for Studying Herpes Simplex Virus InfectionPoojabahen Tajpara, Michael Mildner, Ralf Schmidt, et al.
The Journal of Investigative Dermatology|November 4, 2011
Human dermis harbors distinct mesenchymal stromal cell subsetsChristine Vaculik, Christopher Schuster, Wolfgang Bauer, et al.
The Journal of Experimental Medicine|January 14, 2009
HLA-DR+ leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cellsChristopher Schuster, Christine Vaculik, Christian Fiala, et al.
Dermatology and Therapy|July 7, 2022
Patient Characteristics and Treatment Patterns in European Pediatric Patients with Psoriasis: A Real-World, Cross-Sectional StudyMichael Sticherling, Tess McPherson, Raúl de Lucas Laguna, et al.
Clinical, Cosmetic and Investigational Dermatology|October 26, 2023
Effectiveness of Biologics, Patient-Reported Outcomes, and Clinical Photography in a Subset of Patients with Moderate-to-Severe Psoriasis: Week 12 Results from the Psoriasis Study of Health Outcomes (PSoHO)Massimo Travaglini, Julia-Tatjana Maul, Christian Kors, et al.
Frontiers in Medicine|July 17, 2023
Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO)Stefano Piaserico, Elisabeth Riedl, Lev Pavlovsky, et al.
The Journal of Dermatological Treatment|October 2, 2023
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24-28 and 48-52 weeksAlexander Egeberg, Lars Erik Kristensen, Luis Puig, et al.
The Journal of Dermatological Treatment|March 1, 2021
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasisKristian Reich, Curdin Conrad, Lars Erik Kristensen, et al.
Pageof 5